The startup develops digital cell sorting tools that integrate computer vision with cell biology to enhance drug discovery and cell line development. Their technology enables high-throughput identification and single-cell sorting, facilitating rapid B-cell screening at significantly lower costs for drug developers.
Funding
$17.9M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Traditional methods of cell sorting for antibody discovery and cell line development are often expensive, labor-intensive, and can damage cell viability, limiting the throughput and efficiency of drug development processes. Existing platforms may also lack the ability to rapidly screen and sort single cells based on specific functional characteristics.
Solution
Bioelectronica offers the Hypercell platform, a digital cell sorting solution that integrates computer vision and microfluidics to accelerate antibody discovery and cell line development. The platform enables high-throughput screening and gentle single-cell sorting based on secretion, antigen specificity, or user-defined assays. Combined with the AI-powered AbFinder software, the system streamlines the selection of antibody hits by analyzing and visualizing single-cell antibody sequences. This integrated approach reduces discovery time and costs while preserving cell integrity and viability.
Target Audience
The primary target audience includes researchers and drug developers in the pharmaceutical and biotechnology industries involved in antibody discovery, cell line development, and single-cell analysis.
Features
- High-throughput cell analysis and sorting based on protein secretion, antigen specificity, or custom assays
- Computer vision-based identification and selection of target cells
- Low-pressure microfluidics to maintain cell viability and integrity during sorting
- AbFinderAI software for bioinformatics analysis, visualization, and AI-driven antibody selection
- Automated operation to minimize hands-on time and operator input
- Compact, benchtop design suitable for use in biosafety cabinets
- Customizable assays for diverse applications, including B cell and hybridoma antibody discovery